Healthcare Industry Joins Forces to Create New Digital Services

Twenty-one leading healthcare organisations have joined a formal partnership to tackle the nation’s healthcare challenges by accelerating growth in the digital healthcare market. Founded and led by D Health, the partnership known as ‘the Catalyst’ involves major brands Celisio (owners of Lloyds Pharmacy) and Johnson and Johnson's LifeScan. Other founding members include SMEs such as Isansys, Grey Matters and Cardio QT and healthcare providers Red House Practice Group, Just Checking and Physiomedics. Amongst others, third sector representatives Highland Hospice and Albyn Housing Society have also signed up alongside supporting organisations corporate financiers Opus, sales business Trocar and a leading consumer psychologist.

Advanced talks with potential members from other UK organisations are currently underway, whilst plans to expand the group into Europe during 2014 have progressed with the addition of Spanish cooperative, TIC Biomed to the group.

The Catalyst is set to meet for the first time in London on 5 February 2014 to discuss how it can provide new, low cost products and services for both consumer and provider markets. These could include innovations such as fitness boosting smart phone apps, blood monitoring devices, TV and phone based services for the elderly and self-management software for diabetics.

Market projections for digital healthcare vary widely, but all point to rapid growth over coming years as demand for services increases. According to a recent report conducted by Frost and Sullivan, the worldwide market for healthcare devices will garner over $509.25 billion in the next 10 years, up 87.5 per cent from $271.55 billion in the current decade.

CEO Dr Steven Dodsworth, formerly a scientist with the UK arm of the Human Genome project, leads D Health. He said: "Everyone in the healthcare industry knows what challenges lie ahead - an ageing population, more lifestyle-related ill health and growing constraints on budgets. In a nutshell, there is an increasing demand for services but fewer resources to deliver them.

"Digital healthcare has the potential to deliver popular, personalised, efficient and affordable patient services, and yet, the market isn’t growing fast enough to alleviate pressure on the NHS and local authorities.

"By creating a partnership that embodies all sections of the healthcare industry we aim to create not only new products and services but a new market dynamic based on collaboration. That way the industry can develop urgently required services that support and supplement sustainable health and care services for the future."

Ken Spooner from the Red House Group of Surgeries added: "The Catalyst offers the opportunity for developers of digital healthcare products to work with those who understand patients' needs, helping them to come up with solutions that can deliver and be part of the NHS healthcare offering in the future."

For further information, please visit:
http://www.dhcl.org

Digital healthcare is a holistic term incorporating telemedicine, telehealth, telecare, E-Health, M-Health, Health IT and Assisted Living. As aging populations, lifestyle related diseases and other social and economic drivers continue to dominate global healthcare systems, digital healthcare is rapidly emerging as a key solution for delivering sustainable health and care for the future.

D Health is a specialist consultancy which provides support services to the global digital healthcare community. Combined, D Health’s core team has over 70 years of experience in healthcare as academics, public servants, industry professionals and business leaders. Calling on its industry experience and networks, D Health’s expertise lies in its ability to identify funding, provide market intelligence, scope opportunities, design business/service models and broker partnerships.

The D Health Catalyst is a market accelerator programme that aims to work with leading organisation from the UK and Europe to drive rapid development of the digital healthcare market. D Health aims to stimulate interaction and development by ensuring the Catalyst represents a full cross-section of the market, from SMEs and blue chip companies to state providers and investors. By achieving this, Catalyst members can work in true collaboration, giving them new insight whilst reducing risk, thereby providing a competitive edge.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...